BioNTech SE (BNTX) Gross Profit (2018 - 2025)
BioNTech SE (BNTX) posted Gross Profit of $668.3 million for Q4 2025, down 58.29% on a QoQ basis from $1.6 billion in Q3 2025, and down 33.93% year-over-year from $1.0 billion in Q4 2024.
BioNTech SE (BNTX) has 8 years of Gross Profit data on file, last reported at $668.3 million in Q4 2025.
- In Q4 2025, Gross Profit fell 33.93% year-over-year to $668.3 million; the TTM figure through Dec 2025 stood at $2.6 billion (up 12.69% YoY), while the FY2025 annual figure was $2.5 billion, up 641.18% from the prior year.
- Gross Profit declined to $668.3 million in Q4 2025, from $1.6 billion in the prior quarter.
- Across five years, Gross Profit topped out at $7.0 billion in Q3 2021 and bottomed at -$29.1 million in Q2 2024.
- A 5-year average of $2.2 billion and a median of $1.3 billion in 2023 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2021 — Gross Profit soared 13300.85% — and 2024, when it sank 656.28%.
- Year by year, Gross Profit stood at $6.3 billion in 2021, then tumbled by 33.99% to $4.2 billion in 2022, then tumbled by 66.52% to $1.4 billion in 2023, then fell by 27.68% to $1.0 billion in 2024, then plunged by 33.93% to $668.3 million in 2025.
- The last three Gross Profit figures came in at $668.3 million (Q4 2025), $1.6 billion (Q3 2025), and $208.7 million (Q2 2025), per Business Quant data.